Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting

Published:2017-08-08 Issue:9 Volume:6 Page:2017-2033
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Thein Hla-Hla¹²^ORCID,Isaranuwatchai Wanrudee³⁴,Qiao Yao¹,Wong Kenny¹,Sapisochin Gonzalo⁵,Chan Kelvin K. W.⁶⁷⁸,Yoshida Eric M.⁹,Earle Craig C.²⁸¹⁰¹¹

Affiliation:

1. Dalla Lana School of Public Health; University of Toronto; Toronto Ontario Canada

2. Institute for Clinical Evaluative Sciences; Toronto Ontario Canada

3. Centre for Excellence in Economic Analysis Research; The HUB Li Ka Shing Knowledge Institute; St. Michael's Hospital; Toronto Ontario Canada

4. Institute of Health Policy; Management and Evaluation; University of Toronto; Toronto Ontario Canada

5. Multi-Organ Transplant; Division of General Surgery; University Health Network; University of Toronto; Toronto Ontario Canada

6. Odette Cancer Centre; Sunnybrook Health Sciences Centre; Toronto Ontario Canada

7. Department of Medicine; University of Toronto; Toronto Ontario Canada

8. Canadian Centre for Applied Research in Cancer Control (ARCC); Toronto Ontario Canada

9. University of British Columbia; Division of Gastroenterology; Vancouver British Columbia Canada

10. Ontario Institute for Cancer Research; Toronto Ontario Canada

11. Cancer Care Ontario; Toronto Ontario Canada

Funder

Institute for Clinical Evaluative Sciences

Cancer Care Ontario

Ontario Ministry of Health and Long-Term Care

Ontario Institute for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1119/fullpdf

Reference55 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis;Pocobelli;Liver Int.,2008

3. Review article: the changing epidemiology of hepatocellular carcinoma in Canada;Dyer;Aliment. Pharmacol. Ther.,2005

4. Canadian Cancer Society's Advisory Committee on Cancer Statistics Canadian Cancer Statistics 2013. Toronto, ON, Canadian Cancer Society 2013 http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/canadian-cancer-statistics-2013-EN.pdf

5. Hepatocellular carcinoma;El-Serag;N. Engl. J. Med.,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?;Clinical and Molecular Hepatology;2023-10-01

2. Research Consensus Panel Follow-Up: A Systematic Review and Update on Cost Research in IR;Journal of Vascular and Interventional Radiology;2023-07

3. Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?;Current Oncology;2023-04-07

4. Rapid Review of Real-World Cost-Effectiveness Analyses of Cancer Interventions in Canada;Current Oncology;2022-09-30

5. Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real‐world clinical practice;Hepatology Research;2022-03-03